Home › Pulmonary Hypertension › Florida
Pulmonary Hypertension clinical trials in Florida
12 studies for Pulmonary Hypertension are looking for participants at sites in Florida.
Cities in Florida
- Orlando4 studies
- Gainesville3 studies
- Davie3 studies
- Naples3 studies
- Tampa3 studies
- Jacksonville3 studies
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07234032A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Cleveland Clinic Florida - Weston, Weston
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 10, 2026 · NCT07214376Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Shands at the University of Florida, Gainesville
- Cleveland Clinic Florida, Weston
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06526195Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06911632Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07179380A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 14, 2026 · NCT07285655A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 8, 2026 · NCT07175038A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07816185A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Jul 31, 2026 · NCT06770023Pulmonary Hypertension Association Registry
- Mayo Clinic Florida, Jacksonville
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.